Literature DB >> 3084651

Expression and function of an early activation marker restricted to human B cells.

H Kikutani, R Kimura, H Nakamura, R Sato, A Muraguchi, N Kawamura, R R Hardy, T Kishimoto.   

Abstract

A B cell-specific monoclonal antibody (anti-Ba) was prepared. In two-color FACS analysis the anti-Ba reacted with a subpopulation of Ig+ or B1+ cells obtained from tonsils, but did not react with most B1+ cells derived from PBL. Activation of B cells from PBL with TPA or anti-mu induced Ba expression and the addition of PHA-conditioned supernatant with anti-mu-enhanced Ba expression. Other B cell activators, such as Staphylococcus aureus Cowan I (Staph-A) or PWM plus T cells, could induce Ba expression. Ba expression was observed 6 hr after stimulation and reached a peak level at 72 hr. Ba expression was strictly restricted to B cells. H-7, a specific inhibitor of protein kinase C (C-kinase), displayed a dose-dependent inhibitory effect on Ba expression, showing dependency on C-kinase for Ba expression. Anti-Ba inhibited B cell proliferation induced by anti-mu and B-BCGF distinct from BSF-1. The results presented in this study suggest that the Ba antigen on B cells may be comparable to the Tac antigen on T cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3084651

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Roles of protein kinase C and G proteins in activation of murine resting B lymphocytes by endotoxin-associated protein.

Authors:  J R Bandekar; R Castagna; B M Sultzer
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

2.  NDA3: a differentiation antigen associated with the receptor for B cell growth factor.

Authors:  N Suciu-Foca; C Rohowsky-Kochan; S J Rosochacki; E Cristea; J D Cai; E Reed; D W King
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

3.  Effect of recombinant human tumour necrosis factor beta (TNF beta) on activation, proliferation and differentiation of human B lymphocytes.

Authors:  H Zola; A Nikoloutsopoulos
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

4.  mAb 104, a new monoclonal antibody, recognizes the B7 antigen that is expressed on activated B cells and HTLV-1-transformed T cells.

Authors:  A Vallé; P Garrone; H Yssel; J Y Bonnefoy; A S Freedman; G Freeman; L M Nadler; J Banchereau
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

5.  An activation antigen on a subpopulation of B lymphocytes identified by the monoclonal antibody CMRF-17.

Authors:  S F Peach; S E Davidson; J L McKenzie; J C Nimmo; D N Hart
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

Review 6.  Surface antigens associated with human B cell activation.

Authors:  L K Jung
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

7.  Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines.

Authors:  M Birkenbach; D Liebowitz; F Wang; J Sample; E Kieff
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

8.  Two-color immunofluorescence and flow cytometric analysis of lamina propria lymphocyte subsets in ulcerative colitis and Crohn's disease.

Authors:  M Senju; K C Wu; Y R Mahida; D P Jewell
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

9.  A case of human B cell leukemia that implicates an autocrine mechanism in the abnormal growth of Leu 1 B cells.

Authors:  N Kawamura; A Muraguchi; A Hori; Y Horii; S Mutsuura; R R Hardy; H Kikutani; T Kishimoto
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

10.  Fc epsilon receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching.

Authors:  H Kikutani; M Suemura; H Owaki; H Nakamura; R Sato; K Yamasaki; E L Barsumian; R R Hardy; T Kishimoto
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.